ChemicalBook Chinese Germany Japanese Korean

广州弗尔博生物科技有限公司 Company Information

Company Name:    Guangzhou Fu'erbo Biological Technology Co.,Ltd.
Tel:    -
Email:    1536198927@qq.com
Nationality:    China
WebSite:    www.chemicalbook.com/supplier/25444902/
Product List:    9136
42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92

Product List
Fluorescence signal intensity of hair cells
Osteotoxicity
Bone mineral density (fluorescence signal intensity); Number of vertebrae.
Behavioral toxicity
Behavior
Carcinogenicity (mice)
Skin irritation; Muscle texture; Quantification of skin apoptotic cells; Skin pigment changes.
Immunotoxicity
Macrophage function
Ocular toxicity
Eye size; Ocular apoptotic cells; Ocular vascular area; Ocular histopathology.
Skin toxicity
Phenotypic observation
Median lethal concentration
Mortality; Evaluation of median lethal concentration (LC50).
Genotoxicity
inflammatory reaction
Number of neutrophils; Expression level of inflammatory factors.
Anaphylactic reaction
Tryptase expression level (OD value); Anaphylactic reaction test.
Gastrointestinal toxicity
Intestinal morphology; Intestinal peristalsis requires motor function.
Comet experiment; Genotoxicity evaluation.
Drug stability test
Audiotoxicity
Cardiovascular toxicity heart rate; Heart rhythm; The incidence of pericardial edema; Incidence of bleeding; Incidence of changes in blood flow velocity; Incidence of thrombosis
Incidence of acute toxicity (brain, jaw, eye, kidney, intestine, trunk / tail / spinal cord / somite, body coloring, circulatory system, body edema, bleeding)
Screening model of therapeutic agents for osteoporosis
The incidence of egg coagulation; No heart rate; Hatching rate; The incidence of no somite formation; Incidence of tail non separation;
Incidence of developmental toxicity and teratogenicity (brain, jaw, eye, kidney, intestine, trunk / tail / spinal cord / somite, body coloring, circulatory system, body edema, bleeding)
Drug safety evaluation model index
Embryotoxicity (OECD standard)
Number of hematotoxic neutrophils; Number of macrophages; Number of red blood cells (signal intensity); Blood flow.
Vitellogenin (VTG) content detection; The expression of genes related to hypothalamic pituitary gonadal axis was detected.
Reproductive toxicity and reproductive ability evaluation; Gonadal growth evaluation; Histological sections of gonads;
Skeletal muscle
Cytochrome P450 analysis
Screening model of hepatoprotective drugs
Liver kidney model
Mouse bradycardia model
Cartilage injury model
Screening model of bone development promoters
Promoting tissue regeneration / wound healing
Analgesic drug screening
Fluorescence signal intensity of apoptotic cells in central nervous system;
Behavior (touch response, movement influence, light and dark influence);
neurotoxicity
apoptotic cell
Gastrointestinal peristalsis function (autonomic nerve).
Peripheral motor nerve length; Incidence of brain degeneration;
The incidence of renal capsule edema;.
Nephrotoxicity
Degree of liver degeneration; Yolk sac size.
Hepatotoxicity (juvenile fish)
Fluorescence signal intensity of apoptotic cells (AO staining, TUNEL staining)
Screening model of renal protective agents
Preclinical evaluation of antiviral research and development
Drug evaluation and testing items (outsourcing entrusted experiment)
Animal long-term toxicity test
Animal hybridization experiment
Preclinical evaluation of cardiac drugs
Preclinical spinal cord injury experiment
Modeling animal
Preclinical drug experiment preclinical research (outsourcing entrusted experiment)
Animal hemostatic model
Animal analgesic model
Animal modeling technology service
Animal movement system model
Animal movement model
Screening model of antialcoholic agents
Pharmacodynamic evaluation model of slimming drugs
Screening model of energy metabolism regulator
Fat metabolism model
Hypolipidemic model
Induction model of caspase activity
Screening model of P-glycoprotein inhibitors
Angiogenesis inhibitor screening
Apoptosis inhibitor screening model
Induction model of high sugar and high fat diet
Preclinical evaluation of reproductive toxicity
Efficacy evaluation model of drug efficacy evaluation system
Anti angiogenesis model
Screening model of gastrointestinal motility inhibitors
Metabolic system
Screening model of angiogenesis promoters
Intestinal digestive function
Intestinal mucus secretion function
Protective model of vascular endothelial injury
PM2. 5. Screening model of drainage promoters
Platelet aggregation thrombosis model
Spleen yang deficiency model
Mitochondrial function
Cardio cerebrovascular
Uric acid model
Oxygen free radical (ROS) scavenger screening model
Drug screening model for the treatment of heart failure
Induced qi stagnation and blood stasis thrombosis model
Erythrocyte thrombosis model
Myocardial injury protective agent screening model
Safety evaluation
42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92

Copyright 2007©  ChemicalBook. All rights reserved.